Labetuzumab

Revision as of 20:20, 27 September 2011 by WikiBot (talk | contribs) (Protected "Labetuzumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab

WikiDoc Resources for Labetuzumab

Articles

Most recent articles on Labetuzumab

Most cited articles on Labetuzumab

Review articles on Labetuzumab

Articles on Labetuzumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Labetuzumab

Images of Labetuzumab

Photos of Labetuzumab

Podcasts & MP3s on Labetuzumab

Videos on Labetuzumab

Evidence Based Medicine

Cochrane Collaboration on Labetuzumab

Bandolier on Labetuzumab

TRIP on Labetuzumab

Clinical Trials

Ongoing Trials on Labetuzumab at Clinical Trials.gov

Trial results on Labetuzumab

Clinical Trials on Labetuzumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Labetuzumab

NICE Guidance on Labetuzumab

NHS PRODIGY Guidance

FDA on Labetuzumab

CDC on Labetuzumab

Books

Books on Labetuzumab

News

Labetuzumab in the news

Be alerted to news on Labetuzumab

News trends on Labetuzumab

Commentary

Blogs on Labetuzumab

Definitions

Definitions of Labetuzumab

Patient Resources / Community

Patient resources on Labetuzumab

Discussion groups on Labetuzumab

Patient Handouts on Labetuzumab

Directions to Hospitals Treating Labetuzumab

Risk calculators and risk factors for Labetuzumab

Healthcare Provider Resources

Symptoms of Labetuzumab

Causes & Risk Factors for Labetuzumab

Diagnostic studies for Labetuzumab

Treatment of Labetuzumab

Continuing Medical Education (CME)

CME Programs on Labetuzumab

International

Labetuzumab en Espanol

Labetuzumab en Francais

Business

Labetuzumab in the Marketplace

Patents on Labetuzumab

Experimental / Informatics

List of terms related to Labetuzumab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Labetuzumab is a humanized monoclonal antibody used to treat cancer.


Template:Humanizedmonoclonals Template:SIB

Template:WikiDoc Sources